Circulating Natural Killer Cells as Prognostic Value for Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Correlation with Sarcopenia.
Riccardo PofiCarla PandozziFrancesca SciarraFederica CampoloAlain J GelibterGrazia SirgiovanniEnrico CortesiAndrea LenziAndrea M IsidoriEmilia SbardellaMary Anna VenneriPublished in: Cancers (2023)
Peripheral NK cells could represent a non-invasive and useful tool to predict ICI therapy response in NSCLC patients, and the association of low NK cell levels with sarcopenia deserves even more attention in clinical evaluation.
Keyphrases
- nk cells
- clinical evaluation
- natural killer cells
- end stage renal disease
- skeletal muscle
- ejection fraction
- small cell lung cancer
- newly diagnosed
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- working memory
- stem cells
- advanced non small cell lung cancer
- bone marrow
- mesenchymal stem cells
- tyrosine kinase